Acinetobacter species isolates from a range of environments: Species survey and observations of antimicrobial resistance

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 2, 2012, Pages 177-180

  Choi, Ji Young ^a   Kim, Yejin ^a   Ko, Eun Ah ^b   Park, Young Kyoung ^a   Jheong, Weon Hwa ^c   Ko, GwangPyo ^d   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Neulpureun Middle School   (South Korea)

^c National Institute of Environmental Research   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Acinetobacter baumannii; Colistin; Imipenem

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; RIFAMPICIN; RNA 16S; SULTAMICILLIN; TETRACYCLINE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PARVUS; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLA GIM GENE; BLA IMP GENE; BLA KPC GENE; BLA NDM1 GENE; BLA OXA-23 GENE; BLA OXA-24 GENE; BLA OXA-51 GENE; BLA OXA-58 GENE; BLA SIM GENE; BLA VIM GENE; ENZYME ACTIVITY; GENE SEQUENCE; GENOTYPE; GENUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; SOIL MICROFLORA; SOUTH KOREA; SPECIES IDENTIFICATION;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DNA, RIBOSOMAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84866144237     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.06.023     Document Type: Article

References (21)

1. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009, 53:3628-3634.
2. Adékambi T., Drancourt M., Raoult D. The rpoB gene as a tool for clinical microbiologists. Trend Microbiol 2009, 17:37-45.
3. Arroyo L.A., Herrera C.M., Fernandez L., Hankins J.V., Trent M.S., Hancock R.E. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 2011, 55:3743-3751.
4. Bartual S.G., Seifert H., Hippler C., Luzon M.A.D., Wisplinghoff H., Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4382-4390.
5. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition, M07-A8 2009, CLSI, Wayne, PA.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 21st informational supplement (M100-S21) 2011, CLSI, Wayne, PA.
7. Drancourt M., Berger P., Raoult D. Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol 2004, 42:2197-2202.
8. Espinal P., Marti S., Vila D. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 2012, 80:56-60.
9. Falagas M.E., Karveli E.A., Kelesidis I., Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007, 26:857-868.
10. Franklin C., Liolios L., Peleg A.Y. Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing Gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006, 44:3139-3144.
11. Kang C.I., Chung D.R., Peck K.R., Song J.H. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED. Am J Emerg Med 2012, The Korean Network for Study on Infectious Diseases (KONSID), (In press).
12. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007, 60:1163-1167.
13. La Scola B., Gundi V.A., Khamis A., Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006, 44:827-832.
14. Lee K., Yum J.H., Yong D., Lee H.M., Kim H.D., Docquier J.D., et al. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005, 49:4485-4491.
15. Lee J.Y., Ko K.S. Antimicrobial resistance and clones of Acinetobacter species and Pseudomonas aeruginosa. J Bact Virol 2012, 42:1-8.
16. Moffatt J.H., Harper M., Harrison P., Hale J.D., Vinogradov E., Seemann T., et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010, 54:4971-4977.
17. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008, 358:1271-1281.
18. Nemec A., Dijkshoorn L., Cleenwerck I., De Baere T., Janssens D., Van Der Reijden T.J., et al. Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol 2003, 53:1563-1567.
19. Park Y.K., Sung S.I., Park K.H., Cheong H.S., Peck K.R., Song J.H., et al. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis 2009, 64:51-59.
20. Park Y.K., Jung S.I., Park K.H., Kim D.H., Choi J.Y., Kim S.H., et al. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii isolates from a single hospital in Korea over 7 years. J Med Microbiol 2012, 61:71-79.
21. Zeana C., Larson E., Sahni J., Bayuga S.J., Wu F., Della-Latta P. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir?. Infect Control Hosp Epidemiol 2003, 24:275-279.